No products in the cart.
MyDekla (DAKLINZA) Daclatasvir 60mg online
Roll over image to zoom in
Click to open expanded view
Daclatasvir 60mg is a hepatitis C virus (HCV) NS5A inhibitor indicated for use with sofosbuvir, with or without ribavirin, for the treatment of chronic HCV genotype 1 or 3 infection. Limitations of Use:
• Sustained virologic response (SVR12) rates are reduced in genotype 3 patients with cirrhosis receiving Daclatasvir 60mg in combination with sofosbuvir for 12 weeks.